Table 2.
The expected relative reduction (%) of observed NIDs compared to expected NIDs in Yinchuan in 2020
| Infectious disease | Before (%) (95% CI) | Level 1 (%) (95% CI) | Level 2 (%) (95% CI) | Level 3 (%) (95% CI) | Total (%) (95% CI) |
|---|---|---|---|---|---|
| Overall | 16.32(-44.93,41.18) | 65.65(-65.86,80.84) | 45.95(-98.00,68.70) | 52.72(20.84,66.30) | 50.12(8.25,65.75) |
| Respiratory infectious diseases | 38.8(23.87,48.83) | 67.46(47.92,76.34) | 73.14(61.71,79.31) | 67.06(47.72,75.95) | 65.27(47.36,74.08) |
| Tuberculosis | 18.66(-26.71,40.11) | 38.79(5.69,54.69) | 12.93(-30.5,34.67) | 21.22(-30.71,43.62) | 21.00(-26.91,42.65) |
| Scarlet Fever | 28.36(-86.31,55.66) | 90.85(-130.84,96.02) | 92.18(74.31,95.38) | 85.42(73.02,90.01) | 83.04(64.19,88.89) |
| Influenza | 40.02(8.84,55.30) | 82.39(32.06,89.88) | 87.76(-129.57,94.93) | 76.80(-121.34,92.49) | 68.64(-209.70,86.28) |
| Mumps | 74.91(-746.66,41.92) | 92.67(-607.78,66.75) | 75.58(-25.54,76.13) | 68.7(-349.01,54.64) | 71.88(-276.25,58.40) |
| Others | 100.00(-100.00,100.00) | 100.00(-100.00,100.00) | -7.73(-105.05,95.38) | 97.68(-100.81,99.52) | 94.14(-101.56,98.98) |
| Intestinal infectious diseases | -98.86(-324.73,31.07) | 73.28(-127.52,91.01) | 52.61(-187.61,81.35) | 62.26(16.65,75.61) | 58.45(-35.42,75.46) |
| Dysentery | -25.21(-244.03,56.36) | 34.47(-138.87,82.22) | 36.54(-160.92,79.14) | 40.75(-173.09,66.77) | 37.5(-5311.22,68.57) |
| Hand-Foot-And-Mouth Disease | 25.04(-109.20,92.62) | 94.68(-100.20,99.81) | 91.76(-101.08,99.15) | 96.39(87.52,97.89) | 95.78(-529.05,97.90) |
| Infectious Diarrhoea | 13.52(-46.52,38.66) | 80.32(51.69,87.65) | 52.28(-20.09,70.22) | 28.60(-21.11,49.37) | 33.68(-19.71,54.13) |
| Others | -178.38(-116.14,72.55) | -360.89(-118.74,78.12) | -277.57(-183.08,42.31) | -178.89(-175.74,50.92) | -271.23(-164.20,52.30) |
| Sexually transmitted or bloodborne diseases | 4.80(-37.92,27.31) | 65.38(45.05,74.73) | 37.09(-5.22,55.13) | 34.63(-36.14,56.99) | 35.01(-23.21,55.86) |
| HIV/AIDS | 52.65(-11.18,69.92) | 84.12(62.42,89.94) | 25.81(-75.96,53) | 10.61(-109.79,43.20) | 22.74(-81.78,50.94) |
| Gonorrhoea | -145.97(-424.46,10.82) | 2.88(-233.48,64.39) | -38.88(-366.98,44.89) | -38.5(-280.02,49.99) | -42.67(-297.51,47.59) |
| Syphilis | 21.6(-20.53,41.90) | 71.43(56.54,78.72) | 26.2(-14.99,45.66) | 17.5(-51.38,43.30) | 24.09(-30.73,46.52) |
| Hepatitis B | -15.42(-134.26,23.42) | 59.99(-6.77,75.38) | 57.98(-136.75,76.94) | 7.86(-199.81,68.48) | 22.4(-342.43,66.55) |
| Hepatitis C | 23.96(-43.4,48.26) | 77.19(57.92,84.35) | 34.53(-20.14,55.01) | 24.51(-44.44,48.90) | 30.66(-31.14,52.87) |
| Natural focal diseases and vector-borne infectious diseases | -6.55(-910.87,43.76) | -21.06(-218.45,59.94) | -36.87(-768.49,25.71) | -53.25(-391.98,9.24) | -46.86(-523.74,16.77) |
| Brucellosis | -6.69(-530.32,41.73) | 14.39(-629.27,60.4) | -35.69(-468.22,22.96) | -63.92(-1181.11,12.44) | -52.5(-1032.07,18.24) |
| Hydatid disease | -89.09(-408.17,27.65) | 100.00(-100.00,100.00) | 81.91(-167.95,92.02) | -22.7(-205.82,61.16) | 9.01(-211.08,67.73) |
| Others | 55.52(-109.70,93.25) | 100.00(-100.00,100.00) | 75.44(-110.29,94.40) | 81.76(-109.73,95.29) | 80.5(-108.85,95.36) |
# Before denotes the time frame before emergency response against COVID-19, Level 1, Level 2 and Level 3 are time frames corresponding to different emergency response levels. More details can be seen in Table S3